Amiodarone-induced Pulmonary Toxicity within a Short Period of the Initiation of Amiodarone Therapy: A Case Report.
10.4266/kjccm.2011.26.2.117
- Author:
Woo Jin JANG
1
;
Hae Ri CHON
;
Jin Sung JUNG
;
Seung Hyun YOO
;
Kyu Han KOH
;
Young Min KOH
;
Jung Hyuk KIM
Author Information
1. Division of Cardiology, Department of Internal Medicine, Hanil General Hospital, Seoul, Korea. jimmy5058@hanmail.net
- Publication Type:Case Report
- Keywords:
amiodarone;
pulmonary toxicity;
short course of therapy
- MeSH:
Amiodarone;
Arrhythmias, Cardiac;
Atrial Fibrillation;
Dimaprit;
Humans
- From:The Korean Journal of Critical Care Medicine
2011;26(2):117-121
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Amiodarone is one of the most commonly prescribed antiarrhythmic drug for almost all atrial or ventricular arrythmias. Amiodarone-induced pulmonary toxicity (APT) was first described in 1980 and has potentially serious side effects that are believed to develop in 5% of patients. In general, APT occurs only when high amiodarone doses are used for a long time. However, during short-term therapy of amiodarone, APT is rarely reported. In this report, we describe a case of amiodarone-induced pulmonary toxicity after a short course of amiodarone therapy for atrial fibrillation.
